Encrypted | Login
HyTEC 2113 - Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (2019)

Category: HyTEC

Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) is an effective treatment for medically inoperable early stage NSCLC. The authors quantitatively evaluated published experience with thoracic SBRT for early NSCLC and modeled local control rates as a function of SBRT dose. Early stage NSCLC is radioresponsive when treated with SBRT/SABR. A steep doseresponse relationship exists with high rates of durable LC when physical doses of 43-50 Gy are delivered in 3-5 fractions.

Supplemental Materials 1

International Journal of Radiation Oncology*Biology*Physics

Percy Lee, MD, Billy W. Loo, Jr, MD, PhD, Tithi Biswas, MD, George X. Ding, PhD, Issam M. El Naqa, PhD, Andrew Jackson, PhD, Feng-Ming Kong, MD, PhD, Tamara LaCouture, MD, Moyed Miften, PhD, Timothy Solberg, PhD, Wolfgang A. Tome, PhD, An Tai, PhD, Ellen Yorke, PhD, and X. Allen Li, PhD

I Disagree
I Agree

Show list of all AAPM HyTec Reports »